Activity ratios measure how efficiently a company performs day-to-day tasks, such us the collection of receivables and management of inventory.
Long-term Activity Ratios (Summary)
Based on: 10-K (reporting date: 2021-09-30), 10-K (reporting date: 2020-09-30), 10-K (reporting date: 2019-09-30), 10-K (reporting date: 2018-09-30), 10-K (reporting date: 2017-09-30), 10-K (reporting date: 2016-09-30).
An analysis of the long-term activity ratios from 2016 to 2021 reveals a period of initial volatility followed by relative stabilization and a modest recovery in efficiency metrics toward the end of the period.
- Net Fixed Asset Turnover
- The net fixed asset turnover ratio experienced an initial decline from 3.20 in 2016 to 2.61 in 2017, subsequently recovering to a peak of 3.06 in 2019. After a slight contraction to 2.89 in 2020, the ratio improved to 3.17 by September 30, 2021, nearly returning to the baseline level observed at the start of the period. When accounting for right-of-use assets from operating leases, a similar trend is observed, although the ratio remains consistently lower from 2020 onward, ending at 2.96 in 2021. This divergence suggests that the inclusion of lease assets expanded the asset base, thereby marginally reducing the reported turnover efficiency.
- Total Asset Turnover
- A significant reduction in total asset efficiency occurred between 2016 and 2017, where the ratio dropped from 0.49 to 0.32. For the subsequent four years, the ratio remained relatively stagnant, fluctuating within a narrow range between 0.30 and 0.33. A positive trend emerged in 2021, with the ratio increasing to 0.38, indicating a gradual improvement in the ability to generate revenue from the total asset base, although it remained well below 2016 levels.
- Equity Turnover
- The equity turnover ratio demonstrated a sharp downward trend, falling from 1.64 in 2016 to 0.93 in 2017 and reaching a period low of 0.72 in 2020. This decline indicates a diminishing efficiency in utilizing shareholder equity to drive sales. A modest recovery was recorded in 2021, with the ratio rising to 0.86, though the overall trend over the six-year period reflects a substantial decrease in equity productivity.
In summary, while fixed asset utilization remained resilient and recovered toward its original levels, the overall efficiency of the total asset base and shareholder equity experienced a significant structural decline after 2016, with only partial recoveries observed by the end of the analysis period.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
How can I help you?
Net Fixed Asset Turnover
| Sep 30, 2021 | Sep 30, 2020 | Sep 30, 2019 | Sep 30, 2018 | Sep 30, 2017 | Sep 30, 2016 | ||
|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | |||||||
| Revenues | 20,248) | 17,117) | 17,290) | 15,983) | 12,093) | 12,483) | |
| Property, plant and equipment, net | 6,393) | 5,923) | 5,659) | 5,375) | 4,638) | 3,901) | |
| Long-term Activity Ratio | |||||||
| Net fixed asset turnover1 | 3.17 | 2.89 | 3.06 | 2.97 | 2.61 | 3.20 | |
| Benchmarks | |||||||
| Net Fixed Asset Turnover, Competitors2 | |||||||
| Abbott Laboratories | 4.81 | — | — | — | — | — | |
| Elevance Health Inc. | 34.94 | — | — | — | — | — | |
| Intuitive Surgical Inc. | 3.04 | — | — | — | — | — | |
| Medtronic PLC | 5.77 | — | — | — | — | — | |
| UnitedHealth Group Inc. | 31.81 | — | — | — | — | — | |
| Net Fixed Asset Turnover, Sector | |||||||
| Health Care Equipment & Services | 17.31 | — | — | — | — | — | |
| Net Fixed Asset Turnover, Industry | |||||||
| Health Care | 7.74 | — | — | — | — | — | |
Based on: 10-K (reporting date: 2021-09-30), 10-K (reporting date: 2020-09-30), 10-K (reporting date: 2019-09-30), 10-K (reporting date: 2018-09-30), 10-K (reporting date: 2017-09-30), 10-K (reporting date: 2016-09-30).
1 2021 Calculation
Net fixed asset turnover = Revenues ÷ Property, plant and equipment, net
= 20,248 ÷ 6,393 = 3.17
2 Click competitor name to see calculations.
Between the fiscal years ending September 30, 2016, and September 30, 2021, a strong correlation is observed between the expansion of net fixed assets and the growth of overall revenues. While net fixed assets grew consistently throughout the period, revenue exhibited more volatility but ultimately achieved a significant upward trajectory.
- Revenue and Asset Expansion
- Revenues increased from 12,483 million USD in 2016 to 20,248 million USD in 2021. This growth was supported by a steady investment in property, plant, and equipment (net), which rose from 3,901 million USD to 6,393 million USD over the same six-year period. The continuous annual increase in net fixed assets suggests a strategic, long-term commitment to increasing operational capacity.
- Net Fixed Asset Turnover Trends
- The net fixed asset turnover ratio experienced a notable decline from 3.20 in 2016 to 2.61 in 2017, coinciding with a slight decrease in revenues during a period of increasing asset investment. Following this dip, the ratio recovered to 2.97 in 2018 and remained relatively stable, fluctuating within a narrow band between 2.89 and 3.17 through 2021.
- Asset Utilization Efficiency
- By 2021, the net fixed asset turnover reached 3.17, effectively returning to the efficiency levels observed in 2016. This indicates that the organization successfully scaled its revenue generation to keep pace with significant capital expenditures, maintaining a consistent ability to generate sales from its fixed asset base despite the substantial increase in the absolute value of those assets.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
How can I help you?
Net Fixed Asset Turnover (including Operating Lease, Right-of-Use Asset)
Becton, Dickinson & Co., net fixed asset turnover (including operating lease, right-of-use asset) calculation, comparison to benchmarks
| Sep 30, 2021 | Sep 30, 2020 | Sep 30, 2019 | Sep 30, 2018 | Sep 30, 2017 | Sep 30, 2016 | ||
|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | |||||||
| Revenues | 20,248) | 17,117) | 17,290) | 15,983) | 12,093) | 12,483) | |
| Property, plant and equipment, net | 6,393) | 5,923) | 5,659) | 5,375) | 4,638) | 3,901) | |
| Operating lease right-of-use assets (recorded in Other assets) | 446) | 418) | —) | —) | —) | —) | |
| Property, plant and equipment, net (including operating lease, right-of-use asset) | 6,839) | 6,341) | 5,659) | 5,375) | 4,638) | 3,901) | |
| Long-term Activity Ratio | |||||||
| Net fixed asset turnover (including operating lease, right-of-use asset)1 | 2.96 | 2.70 | 3.06 | 2.97 | 2.61 | 3.20 | |
| Benchmarks | |||||||
| Net Fixed Asset Turnover (including Operating Lease, Right-of-Use Asset), Competitors2 | |||||||
| Abbott Laboratories | 4.26 | — | — | — | — | — | |
| Elevance Health Inc. | 30.12 | — | — | — | — | — | |
| Intuitive Surgical Inc. | 2.93 | — | — | — | — | — | |
| Medtronic PLC | 4.84 | — | — | — | — | — | |
| UnitedHealth Group Inc. | 21.54 | — | — | — | — | — | |
| Net Fixed Asset Turnover (including Operating Lease, Right-of-Use Asset), Sector | |||||||
| Health Care Equipment & Services | 13.89 | — | — | — | — | — | |
| Net Fixed Asset Turnover (including Operating Lease, Right-of-Use Asset), Industry | |||||||
| Health Care | 6.75 | — | — | — | — | — | |
Based on: 10-K (reporting date: 2021-09-30), 10-K (reporting date: 2020-09-30), 10-K (reporting date: 2019-09-30), 10-K (reporting date: 2018-09-30), 10-K (reporting date: 2017-09-30), 10-K (reporting date: 2016-09-30).
1 2021 Calculation
Net fixed asset turnover (including operating lease, right-of-use asset) = Revenues ÷ Property, plant and equipment, net (including operating lease, right-of-use asset)
= 20,248 ÷ 6,839 = 2.96
2 Click competitor name to see calculations.
Between 2016 and 2021, revenues exhibited a general upward trajectory, increasing from 12,483 million US$ to 20,248 million US$. Concurrently, there was a steady and uninterrupted expansion of net property, plant, and equipment, including right-of-use assets, which rose from 3,901 million US$ to 6,839 million US$. This indicates a consistent long-term commitment to increasing the organization's physical and operational capacity.
- Net Fixed Asset Turnover Fluctuations
- The net fixed asset turnover ratio experienced volatility throughout the analyzed period, starting at 3.20 in 2016 and ending at 2.96 in 2021. A significant decline was observed in 2017, where the ratio dropped to 2.61. This contraction was driven by a slight decrease in annual revenues occurring simultaneously with a substantial increase in the net fixed asset base.
- Asset Utilization and Recovery Patterns
- Following the 2017 low, asset efficiency improved for two consecutive years, reaching 3.06 by 2019. A subsequent decline to 2.70 occurred in 2020, coinciding with a period of stagnant revenue growth despite continued investment in fixed assets. However, a recovery to 2.96 was achieved in 2021, as revenue growth of approximately 18% outperformed the growth rate of the asset base.
- Relationship Between Investment and Revenue Generation
- The data reveals a pattern where the expansion of the fixed asset base preceded periods of revenue acceleration. While the net fixed asset base grew by approximately 75% over the six-year period, the turnover ratio remained relatively stable, fluctuating within a narrow band between 2.61 and 3.20. This suggests that while investment levels increased aggressively, the ability to generate sales from those assets remained consistent over the long term.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
How can I help you?
Total Asset Turnover
| Sep 30, 2021 | Sep 30, 2020 | Sep 30, 2019 | Sep 30, 2018 | Sep 30, 2017 | Sep 30, 2016 | ||
|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | |||||||
| Revenues | 20,248) | 17,117) | 17,290) | 15,983) | 12,093) | 12,483) | |
| Total assets | 53,866) | 54,012) | 51,765) | 53,904) | 37,734) | 25,586) | |
| Long-term Activity Ratio | |||||||
| Total asset turnover1 | 0.38 | 0.32 | 0.33 | 0.30 | 0.32 | 0.49 | |
| Benchmarks | |||||||
| Total Asset Turnover, Competitors2 | |||||||
| Abbott Laboratories | 0.57 | — | — | — | — | — | |
| Elevance Health Inc. | 1.41 | — | — | — | — | — | |
| Intuitive Surgical Inc. | 0.42 | — | — | — | — | — | |
| Medtronic PLC | 0.32 | — | — | — | — | — | |
| UnitedHealth Group Inc. | 1.34 | — | — | — | — | — | |
| Total Asset Turnover, Sector | |||||||
| Health Care Equipment & Services | 1.02 | — | — | — | — | — | |
| Total Asset Turnover, Industry | |||||||
| Health Care | 0.62 | — | — | — | — | — | |
Based on: 10-K (reporting date: 2021-09-30), 10-K (reporting date: 2020-09-30), 10-K (reporting date: 2019-09-30), 10-K (reporting date: 2018-09-30), 10-K (reporting date: 2017-09-30), 10-K (reporting date: 2016-09-30).
1 2021 Calculation
Total asset turnover = Revenues ÷ Total assets
= 20,248 ÷ 53,866 = 0.38
2 Click competitor name to see calculations.
The financial data reveals a period of significant asset expansion and subsequent revenue growth between 2016 and 2021. While the overall revenue trajectory is positive, the efficiency of asset utilization experienced a notable decline before beginning a recovery phase in the final year of the period.
- Revenue Performance
- Revenues exhibited a general upward trend, increasing from 12,483 million US dollars in 2016 to 20,248 million US dollars in 2021. A significant acceleration in growth occurred between 2017 and 2018, with a continued climb through 2021, despite a marginal contraction in 2020.
- Asset Base Evolution
- The total asset base underwent rapid expansion in the early part of the analyzed period. Assets grew from 25,586 million US dollars in 2016 to 53,904 million US dollars by 2018. Following this period of aggressive growth, the asset base stabilized, fluctuating slightly between 51,765 million and 54,012 million US dollars from 2019 through 2021.
- Total Asset Turnover Analysis
- The total asset turnover ratio declined sharply from 0.49 in 2016 to 0.30 in 2018, reflecting that the growth in the asset base significantly outpaced the growth in revenues during those years. This indicates a decrease in the efficiency of generating sales from the invested assets. However, from 2019 to 2021, the ratio began a gradual recovery, reaching 0.38 by September 30, 2021. This improvement is attributed to the stabilization of the asset base coinciding with continued revenue growth, suggesting an increase in operational efficiency and better utilization of the expanded asset base.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
How can I help you?
Equity Turnover
| Sep 30, 2021 | Sep 30, 2020 | Sep 30, 2019 | Sep 30, 2018 | Sep 30, 2017 | Sep 30, 2016 | ||
|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | |||||||
| Revenues | 20,248) | 17,117) | 17,290) | 15,983) | 12,093) | 12,483) | |
| Shareholders’ equity | 23,677) | 23,765) | 21,081) | 20,994) | 12,948) | 7,633) | |
| Long-term Activity Ratio | |||||||
| Equity turnover1 | 0.86 | 0.72 | 0.82 | 0.76 | 0.93 | 1.64 | |
| Benchmarks | |||||||
| Equity Turnover, Competitors2 | |||||||
| Abbott Laboratories | 1.20 | — | — | — | — | — | |
| Elevance Health Inc. | 3.80 | — | — | — | — | — | |
| Intuitive Surgical Inc. | 0.48 | — | — | — | — | — | |
| Medtronic PLC | 0.59 | — | — | — | — | — | |
| UnitedHealth Group Inc. | 3.98 | — | — | — | — | — | |
| Equity Turnover, Sector | |||||||
| Health Care Equipment & Services | 2.42 | — | — | — | — | — | |
| Equity Turnover, Industry | |||||||
| Health Care | 1.67 | — | — | — | — | — | |
Based on: 10-K (reporting date: 2021-09-30), 10-K (reporting date: 2020-09-30), 10-K (reporting date: 2019-09-30), 10-K (reporting date: 2018-09-30), 10-K (reporting date: 2017-09-30), 10-K (reporting date: 2016-09-30).
1 2021 Calculation
Equity turnover = Revenues ÷ Shareholders’ equity
= 20,248 ÷ 23,677 = 0.86
2 Click competitor name to see calculations.
An analysis of the company's investment activity from 2016 to 2021 reveals a significant divergence between the growth of the equity base and the growth of revenue, leading to a decline in overall equity utilization efficiency.
- Revenue Growth Trends
- Revenues demonstrated a consistent long-term upward trajectory, increasing from 12,483 million US$ in 2016 to 20,248 million US$ in 2021. While growth was steady, a marginal contraction was observed between 2019 and 2020 before a strong recovery in 2021.
- Shareholders' Equity Accumulation
- The capital base expanded substantially over the analyzed period, rising from 7,633 million US$ in 2016 to 23,677 million US$ in 2021. A particularly sharp increase occurred between 2017 and 2018, where equity grew by approximately 62%, significantly increasing the total equity available for investment.
- Equity Turnover Performance
- The equity turnover ratio experienced a sharp contraction, falling from a peak of 1.64 in 2016 to 0.93 in 2017. For the remainder of the period, the ratio fluctuated within a lower range, reaching a minimum of 0.72 in 2020 and ending at 0.86 in 2021. This trend indicates that the expansion of shareholders' equity outpaced revenue growth, resulting in a lower capacity to generate sales relative to the invested equity base.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
How can I help you?